微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD(NSPR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-22-006180 Act: 34 Size: 9 MB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-22-005566 Act: 34 Size: 291 KB 网页链接
$InspireMD(NSPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-22-000422 Act: 34 Size: 69 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-22-000829 Act: 34 Size: 4 MB 网页链接
$InspireMD(NSPR)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-000554 Size: 7 KB 网页链接
$InspireMD(NSPR)$ 内部交易: 2021-12-28,Director,ROUBIN GARY S ,买入,16393普通股, $3.08
$InspireMD(NSPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-032757 Size: 6 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-21-030697 Act: 34 Size: 7 MB 网页链接
$InspireMD(NSPR)$ 内部交易: 2021-12-01,Director,Stuka Paul ,买入,12037普通股, $3.51
$InspireMD(NSPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-030337 Size: 6 KB 网页链接